Items where Author is "Sokolova, K.V."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 5.

Article

Sokolova, K.V. and Podpletnya, O.A. and Konovalova, S.О. and Avdeenko, A.P. and Kovalenko, S.I. (2024) Influence of substituted quinones on the excretory function of the rat kidney and evaluation of the prospects of their use as potential diuretics. Медичні перспективи = Medicni perspektivi (Medical perspectives) (2). pp. 4-10. ISSN 2307-0404 (print), 2786-4804 (online)

Sokolova, K.V. and Podpletnia, O.A. and Konovalova, S.О. and Avdeenko, A.P. and KomarovskaPorokhnyavets, O.Z. and Lubеnets, V.I. and Kovalenko, S.I. (2023) N-arylsulfonyl-2-aroylamino-1,4- quinonе imines and their hydrogenated analogues: prediction of toxicity and prospects for use as diuretics. Медичні перспективи = Medicni perspektivi (Medical perspectives) (2). pp. 20-28. ISSN 2307-0404 (print), 2786-4804 (online)

Sokolova, K.V. and Stavytskyi, V.V. and Konovalov, S.О. and Podpletnya, O.A. and Kovalenko, S.I. and Avdeenko, A.P. (2022) Design and search for prospective diuretics (CA II inhibitors) among aroylhydrazones of esters quinone oxime using in silico and in vivo methodology. Медичні перспективи = Medicni perspektivi (Medical perspectives) (4). pp. 27-37. ISSN 2307-0404 (print), 2786-4804 (online)

Sokolova, K.V. and Stavytskyi, V.V. and Kovalenko, S.I and Podpletnya, O.A. (2022) Directed search for diuretics among 6-substituted pteridine-2,4,7(1H,3H,8H)-triones. Медичні перспективи = Medicni perspektivi (Medical perspectives), 27 (2). pp. 4-15. ISSN 2307-0404 (print), 2786-4804 (online)

Sokolova, K.V. and Stavytskyi, V.V. and Voskoboinik, O.Yu. and Podpletnya, O.A. and Kovalenko, S.I. (2022) In silico and in vivo screening of triamterene synthetic analogues as promising diuretics. Медичні перспективи = Medicni perspektivi (Medical perspectives) (3). pp. 4-15. ISSN 2307-0404 (print), 2786-4804 (online)

This list was generated on Thu Nov 21 02:09:08 2024 EET.